Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients.
Cariti C, Dapavo P, Mastorino L, Ortoncelli M, Siliquini N, Merli M, Avallone G, Giordano S, Fabrizio R, Susca S, Verrone A, Stroppiana E, Quaglino P, Ribero S. Cariti C, et al. Among authors: giordano s. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e233-e235. doi: 10.1111/jdv.17766. Epub 2021 Nov 7. J Eur Acad Dermatol Venereol. 2022. PMID: 34672026 No abstract available.
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks.
Mastorino L, Cantafio Duò VL, Vecco C, Gelato F, Giordano S, Roccuzzo G, Cavaliere G, Avallone G, Ortoncelli M, Ribero S, Quaglino P. Mastorino L, et al. Among authors: giordano s. J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1021-e1023. doi: 10.1111/jdv.18427. Epub 2022 Jul 26. J Eur Acad Dermatol Venereol. 2022. PMID: 35841298 No abstract available.
Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al.
Avallone G, Giordano S, Astrua C, Merli M, Senetta R, Conforti C, Ribero S, Marzano AV, Quaglino P. Avallone G, et al. Among authors: giordano s. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e433-e435. doi: 10.1111/jdv.17959. Epub 2022 Feb 4. J Eur Acad Dermatol Venereol. 2022. PMID: 35067994 No abstract available.
Vaccine development and technology for SARS-CoV-2: Current insight.
Cattel L, Giordano S, Traina S, Lupia T, Corcione S, Angelone L, La Valle G, De Rosa FG, Cattel F. Cattel L, et al. Among authors: giordano s. J Med Virol. 2022 Mar;94(3):878-896. doi: 10.1002/jmv.27425. Epub 2021 Nov 11. J Med Virol. 2022. PMID: 34713912 Free PMC article. Review.
Ozone therapy in COVID-19: A narrative review.
Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, Angelone L, De Rosa FG. Cattel F, et al. Among authors: giordano s. Virus Res. 2021 Jan 2;291:198207. doi: 10.1016/j.virusres.2020.198207. Epub 2020 Oct 25. Virus Res. 2021. PMID: 33115670 Free PMC article. Review.
1,070 results